首页> 美国卫生研究院文献>Scientific Reports >Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods
【2h】

Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods

机译:人类诱导的多能干细胞衍生细胞和机器学习方法预测药物诱导的肾毒性和损伤机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The renal proximal tubule is a main target for drug-induced toxicity. The prediction of proximal tubular toxicity during drug development remains difficult. Any in vitro methods based on induced pluripotent stem cell-derived renal cells had not been developed, so far. Here, we developed a rapid 1-step protocol for the differentiation of human induced pluripotent stem cells (hiPSC) into proximal tubular-like cells. These proximal tubular-like cells had a purity of >90% after 8 days of differentiation and could be directly applied for compound screening. The nephrotoxicity prediction performance of the cells was determined by evaluating their responses to 30 compounds. The results were automatically determined using a machine learning algorithm called random forest. In this way, proximal tubular toxicity in humans could be predicted with 99.8% training accuracy and 87.0% test accuracy. Further, we studied the underlying mechanisms of injury and drug-induced cellular pathways in these hiPSC-derived renal cells, and the results were in agreement with human and animal data. Our methods will enable the development of personalized or disease-specific hiPSC-based renal in vitro models for compound screening and nephrotoxicity prediction.
机译:肾近端小管是药物诱导毒性的主要靶标。在药物开发过程中对近端肾小管毒性的预测仍然很困难。迄今为止,尚未开发出任何基于诱导性多能干细胞衍生肾细胞的体外方法。在这里,我们开发了一种快速的1步方案,用于将人诱导的多能干细胞(hiPSC)分化为近端管状细胞。这些近端管状细胞分化8天后纯度> 90%,可直接用于化合物筛选。通过评估细胞对30种化合物的反应来确定其肾毒性预测性能。使用称为随机森林的机器学习算法自动确定结果。这样,可以以99.8%的训练准确度和87.0%的测试准确度预测人的近端肾小管毒性。此外,我们研究了这些hiPSC来源的肾细胞中损伤的基本机制和药物诱导的细胞途径,其结果与人和动物的数据一致。我们的方法将使针对化合物筛选和肾毒性预测的个性化或疾病特异性基于hiPSC的肾脏体外模型的开发成为可能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号